CD79A and inflammatory bowel disease: While day 5 shows enrichment for innate immune (phagosome), anti-viral response (Influenza A, HTLV- I infection) and mucosal immunoglobulin-mediated response pathways (intestinal immune network for IgA production), day 36 is specifically enriched for adaptive/MHC-mediated immune pathways (T cell receptor signaling, natural killer cell-mediated cytotoxicity, graft-versus-host disease) and genes that have been implicated in IBD pathogenesis (Fig. 6b).